宜華健康(000150.SZ)子公司擬終止收購三溪堂國藥館、三溪堂中醫保健院及三溪中醫藥研究所各65%股權
格隆匯11月22日丨宜華健康(000150.SZ)公佈,2019年11月22日,公司召開第七屆董事會第三十九次會議,審議通過《關於公司子公司終止收購義烏市三溪堂國藥館連鎖有限公司、義烏三溪堂中醫保健院有限公司、義烏市三溪中醫藥研究所各65%股權的議案》,同意達孜賽勒康終止收購朱智彪、潘鬆琴所持有的義烏市三溪堂國藥館連鎖有限公司、義烏三溪堂中醫保健院有限公司、義烏市三溪中醫藥研究所各65%股權。
自原協議簽署以來,雙方共同推進此次收購的進行,達孜賽勒康累計向朱智彪、潘鬆琴支付共計1500萬股權轉讓款。後雙方在原協議關鍵問題上未能達成一致,公司本着審慎原則。雙方經友好協商,決定終止收購義烏市三溪堂國藥館連鎖有限公司、義烏三溪堂中醫保健院有限公司、義烏市三溪中醫藥研究所各65%股權,並與朱智彪、潘鬆琴簽署《達孜賽勒康醫療投資管理有限公司與朱智彪、潘鬆琴關於義烏市三溪堂國藥館連鎖有限公司、義烏三溪堂中醫保健院有限公司、義烏市三溪中醫藥研究所的股權收購協議書之解除協議》。
此次解除協議的簽署,是雙方協商一致的結果,未對公司經營產生重大影響,不存在損害公司及股東利益的情形
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.